Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Clinical Trials
Return to: PBR Home | Contract Research & Services | Clinical Trials | News
Search Refinements

Clinical Trials News

View news from other Pharmaceutical sectors:
76-90 of 4090 results
FDA asks Scynexis to hold initiation of new clinical studies using IV formulation of SCY-078
Scynexis has been asked by the US Food and Drug Administration (FDA) to put a hold on the initiation of any new clinical studies with the intravenous (IV) formulation of SCY-078 until it finishes a review of all available pre-clinical and clinical data of the IV formulation of SCY-078.
Contract Research & Services > Clinical Trials > News
Chi-Med’s colorectal cancer drug shows positive results in phase 3 trial
Hutchison China MediTech has unveiled top-line results from FRESCO, its Phase III pivotal registration trial of fruquintinib in 416 patients with locally advanced or metastatic colorectal cancer (“CRC”) in China, who failed at least two prior chemotherapies, including fluoropyrimidine, oxaliplatin and irinotecan
Contract Research & Services > Clinical Trials > News
PTC Therapeutics' cystic fibrosis drug fails in phase 3 trial
PTC Therapeutics’ protein restoration therapy ataluren failed to meet the primary and secondary endpoints in a phase 3 trial, dubbed Ataluren Confirmatory Trial (ACT CF), in patients with nonsense mutation cystic fibrosis (nmCF).
Contract Research & Services > Clinical Trials > News
Roche's Perjeta meets primary endpoint in breast cancer study
By PBR Staff Writer
A phase III study has demonstrated that Roche’s Perjeta regimen helped people with an aggressive type of early breast cancer live longer without their disease returning compared to Herceptin and chemotherapy.
Contract Research & Services > Clinical Trials > News
Amgen’s Blinatumomab nearly doubles survival time in B-Cell ALL
By PBR Staff Writer
A phase 3 study assessing Amgen’s Blincyto (blinatumomab) significantly improved overall survival (OS) in patients with B-Cell precursor acute lymphoblastic leukemia compared To chemotherapy.
Contract Research & Services > Clinical Trials > News
Kite Pharma's cancer therapy study shows good results in first CAR-T trial
By PBR Staff Writer
Kite Pharma’s axicabtagene ciloleucel demonstrated an objective response rate (ORR) of 82% and a complete response (CR) rate of 54% for patients with aggressive non-Hodgkin lymphoma in the ZUMA-1 trial.
Contract Research & Services > Clinical Trials > News
La Jolla’s blood pressure drug meets primary endpoint in phase 3 trial
By PBR Staff Writer
La Jolla Pharmaceutical’s catecholamine resistant hypotension (CRH) drug, LJPC-501 (angiotensin II) has met its primary endpoint in a phase 3 study.
Contract Research & Services > Clinical Trials > News
Oxford BioMedica’s TroVax phase I/II trial yields encouraging results
Oxford BioMedica announced that a phase I/II clinical trial of MVA-5T4 immunotherapy (TroVax) and low dose cyclophosphamide (CPM) has yielded encouraging results in patients with advanced colorectal cancer (TaCTiCC).
Contract Research & Services > Clinical Trials > News
Merck’s trial of inactivated varicella zoster virus vaccine meets primary end point
By PBR Staff Writer
Merck’s inactivated varicella zoster virus vaccine (VZV), V212, has met its primary endpoint in the first phase III study.
Contract Research & Services > Clinical Trials > News
Cyclacel's leukemia drug for elderly patients fails in phase 3 trial
By PBR Staff Writer
Cyclacel Pharmaceuticals’ leukemia drug for elderly patients failed to meet its primary endpoint in a phase 3 study.
Contract Research & Services > Clinical Trials > News
ProMetic’s pulmonary fibrosis drug yields positive results in phase 2 trial
ProMetic Life Sciences has revealed positive results for PBI-4050 from its open label Phase 2 clinical trial in idiopathic pulmonary fibrosis ("IPF") patients.
Contract Research & Services > Clinical Trials > News
GSK, Innoviva’s Relvar Ellipta shows positive effect in non-inferiority lung function study
By PBR Staff Writer
GlaxoSmithKline (GSK) and Innoviva’s non-inferiority lung function study of Relvar Ellipta has showed positive effect in patients with well-controlled asthma.
Contract Research & Services > Clinical Trials > News
ImmusanT’s phase 1b trial of celiac disease vaccine finds phase 2 dose regimen
ImmusanT has completed a phase 1b clinical trial evaluating the safety and tolerability of Nexvax2 in celiac disease.
Contract Research & Services > Clinical Trials > News
Argos' cancer treatment study recommended to be discontinued for futility
By PBR Staff Writer
An independent data monitoring committee (IDMC) has recommended Argos Therapeutics to halt the clinical trial of rocapuldencel-T cancer vaccine candidate, as it is unlikely to meet the primary endpoint.
Contract Research & Services > Clinical Trials > News
hVIVO says US body begins trial on malaria and Zika vaccine
Biopharmaceutical firm hVIVO PLC on Tuesday said the US National Institute of Health has initiated a phase one clinical trial of AGS-v, an investigational vaccine for mosquito-borne diseases like malaria and Zika.
Contract Research & Services > Clinical Trials > News
76-90 of 4090 results